Table 1.
Patient characteristics
| n = 220 | |
|---|---|
| Age (yrs) | 66.1 ± 14.0 |
| Male sex (n, %) | 165 (75) |
| STEMI at inclusion (n, %) | 90 (40.9) |
| Culprit lesion localization | |
| LAD (n, %) | 66 (30) |
| LCX (n, %) | 49 (22.3) |
| RCA (n, %) | 89 (40.4) |
| Diagonal branch (n, %) | 3 (1.4) |
| Obtuse branch (n, %) | 13 (5.9) |
| Extent of myocardial infarction | |
| Maximal TnT (pg/ml) | 2993 ± 4317 |
| Maximal CK (U/l) | 1195 ± 1494 |
| Maximal CK-MB (U/l) | 151 ± 188 |
| LVEF (%) | 48.6 ± 8.5 |
| Cardiovascular risk profile | |
| T2DM (n, %) | 58 (26.4) |
| HbA1c (%) | 6.2 ± 1.3 |
| Hypertension (n, %) | 143 (65.0) |
| Active nicotine use (n, %) | 68 (30.9) |
| BMI (kg/m2) | 27.1 ± 4.2 |
| Cholesterol (mg/dl) | 206 ± 124 |
| LDLc (mg/dl) | 137 ± 47 |
| HDLc (mg/dl) | 47 ± 14 |
| Triglycerides (mg/dl) | 110 ± 93 |
TnT high sensitive Troponin T, T2DM type 2 diabetes mellitus